TG Therapeutics Inc (TGTX) Ownership

$29.44

$0.02 (-0.07%)
Last update: 03:49 PM EST
Day's range
$28.7
Day's range
$29.53

TG Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 21.85 M $651.30 M   2.57% 15.02%
VANGUARD GROUP INC 01/29/2026 15.84 M $472.22 M   2.06% 10.89%
STATE STREET CORP 02/13/2026 8.48 M $252.79 M   4.68% 5.83%
CLEARBRIDGE INVESTMENTS, LLC 02/11/2026 3.45 M $102.79 M   -25.76% 2.37%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 3.40 M $101.48 M   -1.16% 2.34%
SOLEUS CAPITAL MANAGEMENT, L.P. 02/12/2026 3.14 M $93.58 M   -18.35% 2.16%
GOLDMAN SACHS GROUP INC 02/10/2026 2.05 M $61.14 M   35.00% 1.41%
CONGRESS ASSET MANAGEMENT CO /MA 01/09/2026 1.92 M $57.31 M   100.00% 1.32%
INVESCO LTD. 02/19/2026 1.61 M $47.99 M   47.10% 1.11%
HOOD RIVER CAPITAL MANAGEMENT LLC 02/17/2026 1.58 M $47.14 M   1.83% 1.09%
MORGAN STANLEY 02/13/2026 1.50 M $44.81 M   20.45% 1.03%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 1.46 M $43.55 M   -9.23% 1.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 1.31 M $39.10 M   0.12% 0.90%
TWO SIGMA INVESTMENTS, LP 02/17/2026 1.06 M $31.61 M   19.17% 0.73%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 1.06 M $31.49 M   34.48% 0.73%
CITADEL ADVISORS LLC 02/17/2026 1.01 M $30.14 M   1.85% 0.70%
JANE STREET GROUP, LLC 02/12/2026 969.98 K $28.91 M   -14.07% 0.67%
NUVEEN, LLC 02/12/2026 953.21 K $28.42 M   34.11% 0.66%
BANK OF NEW YORK MELLON CORP 02/10/2026 898.41 K $26.78 M   2.96% 0.62%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 887.45 K $26.45 M   25.29% 0.61%
SQUAREPOINT OPS LLC 02/13/2026 852.52 K $25.41 M   68.94% 0.59%
BANK OF AMERICA CORP /DE/ 02/17/2026 851.11 K $25.37 M   35.82% 0.59%
PRINCIPAL FINANCIAL GROUP INC 02/02/2026 847.79 K $25.27 M   8.11% 0.58%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 778.30 K $23.20 M   -3.74% 0.54%
EVENTIDE ASSET MANAGEMENT, LLC 02/13/2026 716.41 K $21.36 M   -24.95% 0.49%
JANE STREET GROUP, LLC 02/12/2026 689.30 K $20.55 M   72.97% 0.47%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 683.65 K $20.38 M   856.64% 0.47%
MILLENNIUM MANAGEMENT LLC 02/17/2026 675.91 K $20.15 M   132.36% 0.46%
RAYMOND JAMES FINANCIAL INC 02/18/2026 629.95 K $18.77 M   -6.55% 0.43%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 605.95 K $18.06 M   -36.78% 0.42%
TWO SIGMA ADVISERS, LP 02/17/2026 599.60 K $17.87 M   40.03% 0.41%
PENN CAPITAL MANAGEMENT COMPANY, LLC 02/09/2026 538.12 K $16.08 M   3.23% 0.37%
UBS GROUP AG 01/29/2026 537.02 K $16.01 M   -13.14% 0.37%
TREXQUANT INVESTMENT LP 02/17/2026 512.45 K $15.28 M   92.36% 0.35%
BANK OF MONTREAL /CAN/ 02/12/2026 512.38 K $15.27 M   -0.05% 0.35%
ALGERT GLOBAL LLC 02/17/2026 485.19 K $14.46 M   489.03% 0.33%
CITIGROUP INC 02/13/2026 483.53 K $14.41 M   -35.26% 0.33%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 472.79 K $14.09 M   1,725.22% 0.33%
PUBLIC SECTOR PENSION INVESTMENT BOARD 02/13/2026 470.29 K $14.02 M   -11.14% 0.32%
BRIDGEWATER ASSOCIATES, LP 02/13/2026 469.86 K $14.01 M   37.32% 0.32%
BARCLAYS PLC 02/13/2026 446.72 K $13.32 M   -2.51% 0.31%
VOYA INVESTMENT MANAGEMENT LLC 02/12/2026 404.86 K $12.07 M   0.03% 0.28%
02/13/2026 401.60 K $11.97 M   -1.95% 0.28%
WELLS FARGO & COMPANY/MN 02/13/2026 395.68 K $11.80 M   45.11% 0.27%
CITADEL ADVISORS LLC 02/17/2026 385.80 K $11.50 M   5.76% 0.27%
RHUMBLINE ADVISERS 02/13/2026 380.93 K $11.36 M   -5.34% 0.26%
NEW YORK STATE COMMON RETIREMENT FUND 02/12/2026 374.57 K $11.17 M   4.39% 0.26%
683 CAPITAL MANAGEMENT, LLC 02/17/2026 360.00 K $10.73 M   10.77% 0.25%
LEGAL & GENERAL GROUP PLC 02/09/2026 355.52 K $10.60 M   1.11% 0.24%
SWISS NATIONAL BANK 02/12/2026 297.20 K $8.86 M   1.68% 0.20%

TG Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 409 institutional investors and hedge funds held shares of TG Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 21.85 M

VANGUARD GROUP INC: 15.84 M

STATE STREET CORP: 8.48 M

Clearbridge Investments, LLC: 3.45 M

GEODE CAPITAL MANAGEMENT, LLC: 3.4 M

Soleus Capital Management, L.P.: 3.14 M

56.31% of TG Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 110.66 M shares in the last 24 months. This purchase volume represents approximately $3.26 B in transactions.